Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
GfV 2023
Programm
Poster
Personen
Suche
EN
Zurück
Poster Session
Poster exhibition
Viral vectors and gene therapy
Termin
Datum:
28.03.2023
Zeit:
13:00
–
21:00
Ort / Stream:
Viral vectors and gene therapy
Programm
Poster
P 404
Analysis of the prevalence of binding and neutralizing antibodies against 39 human Adenovirus types in student cohorts reveals low-prevalence types and a decline in binding antibody levels during the SARS-CoV-2 pandemic
Xiaoyan Wang (Essen / DE)
Vaccines, Viral vectors and gene therapy
Poster
P 405
Transgene expression knockdown in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene expression across passages
Patrick Neckermann (Regensburg / DE)
Vaccines, Viral vectors and gene therapy
Poster
P 406
Influenza A virus chimeric OP7 defective interfering particles – cell culture-based production and in vivo antiviral efficacy
Lars Pelz (Magdeburg / DE)
Viral vectors and gene therapy
Poster
P 407
Generation of an attenuated chimeric bat influenza A virus live-vaccine prototype
Sebastian Giese (Freiburg / DE)
Viral vectors and gene therapy
Poster
P 408
Activation of the immune response against HCMV via NKG2D signaling
Anna Rebecca Siemes (Hannover / DE)
Viral vectors and gene therapy
Poster
P 409
Impact of deletions in the gene block ORF11-13 in the varicella-zoster virus vaccine strain Oka genome on glycoprotein gE and gI expression in permissive cells
Elena Hildebrand (Kiel / DE)
Viral vectors and gene therapy
Poster
P 410
Varicella zoster virus vaccine strain Oka variants withreduced genome size, reduced pathogenic potential andtheir replication properties in permissive melanoma cells and fibroblasts
Julius Völkl (Kiel / DE)
Viral vectors and gene therapy
Poster
P 411
Novel adenovirus vectors for efficient transduction of human hematopoietic stem cells and peripheral blood monocyte subsets
Dr. Wenli Zhang (Witten / DE)
Viral vectors and gene therapy, Virus receptors and entry
Poster
P 412
Generation of proof-of-principle barcoded recombinant Adenovirus libraries allowing for novel medical and laboratory applications
Julian Fischer (Freiburg / DE)
Vaccines, Viral vectors and gene therapy
Poster
P 413
Novel suspension retroviral packaging cells generated by transposition using transposase encoding mRNA facilitate high vector yields and production in bioreactors
Yasemin van Heuvel (Leverkusen / DE)
Viral vectors and gene therapy
Poster
P 414
CRISPR Cas13 as an antiviral tool against respiratory RNA viruses
Anna Carolina Kuge (Hannover / DE)
Viral vectors and gene therapy
Poster
P 415
Development of improved peptide nanofibrils as transduction enhancers for CAR-T cell therapy
Lena Rauch-Wirth (Ulm / DE)
Viral transformation and oncogenesis, Viral vectors and gene therapy
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz